U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White

U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. gestures as he speaks during an event at the Roosevelt Room of the White House in Washington, D.C., U.S., Dec. 19, 2025. Evelyn Hockstein | Reuters Health and Human Services Secretary Robert F. Kennedy Jr. on Wednesday said he would support a potential ban

Revolutionizing Patient Care: The AI-Powered Conversion of Healthcare The healthcare...

AI’s biggest impact in science is Google DeepMind’s use of a deep learning model to predict the complex structures of proteins — the molecules that drive virtually every process in living cells. But as AI models continue to spit out more candidates for potential treatments, there’s an emerging bottleneck: actually characterizing all those candidates in

Amazon GLP-1 treatment Source: Amazon Inc. Amazon is pushing deeper into the booming weight loss market, unveiling Tuesday a new program that aims to simplify access to popular GLP-1 treatments. The company said its primary care arm, Amazon One Medical, is launching a GLP-1 management program that integrates obesity treatment into routine care. The offering